The microbiome, immunity, and inflammatory bowel disease
Ramnik Xavier, M.D.
Core Member, Director of the Immunology Program and Co-Director of Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard
Kurt J. Isselbacher Professor of Medicine, Harvard Medical School
Microbiome contributions to progressive HIV/SIV infection
Jason Brenchley, Ph.D.
Senior Investigator, Barrier Immunity Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Bacterial Strain Differences in the Reproductive Tract and Their Associated Immunophenotypes
Matthew Hayward, Ph.D.
Research Fellow in Medicine, Ragon Institute of MGH, MIT and Harvard
Vaginal bacteria and HIV acquisition in women
Sujatha Srinivasan, Ph.D.
Senior Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Development of Defined Communities for the Prevention and Treatment of C. difficile Infection
Robert A. Britton, Ph.D.
Professor, Department of Molecular Virology and Microbiology
Member, and Director of the Bioreactor and Cultivation Core, Alkek Center for Metagenomics and Microbiome Research, Baylor College of Medicine
Microbiota Promote MHC Class II Antigen Presentation by Intestinal Epithelial Cells to Initiate Graft-Versus-Host Disease
Motoko Koyama, M.D., Ph.D.
Senior Staff Scientist, Clinical Research Division, Fred Hutchinson Cancer Research Center
Biogeographies of Bacteroides fragilis in early colorectal cancer
Ph.D. Candidate, DePaolo Lab, Molecular Medicine and Mechanisms of Disease (M3D) Program, University of Washington
Predicting and combating biotic and abiotic disruptions to diverse microbiomes
Gautam Dantas, Ph.D.
Professor, Departments of Pathology & Immunology, Biomedical Engineering, and Molecular Microbiology, and the Edison Family Center for Genome Sciences and Systems Biology, Washington University School of Medicine in St. Louis
Kevin Forsberg, Ph.D.
Post-Doctoral Research Fellow, Malik Lab, Basic Sciences Division, Fred Hutchinson Cancer Research Center
Jeffrey McLean, Ph.D.
Associate Professor, School of Dentistry and Adjunct Associate Professor, Department of Microbiology, University of Washington
Sandi Navarro, Ph.D.
Staff Scientist, Public Health Sciences Division, Fred Hutchinson Cancer Research Center
Jeanette Schwensen, B.S.
Research Technician, Koch Lab, Basic Sciences Division, Fred Hutch
Microbiomes in Transition
Janet Jansson, Ph.D.
Chief Scientist for Biology and Lab Fellow, Biological Sciences Division, Pacific Northwest National Laboratory
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity
Bruce Roberts, Ph.D.
Chief Scientific Officer, Vedanta Biosciences
Improving Safety and Scale: The Role of Stool Banks in C. difficile Treatment and in Research
Scott Olesen, Ph.D.
Scientific Director, OpenBiome
Diet, inflammatory bowel disease and the intestinal microbiome
David L. Suskind, M.D.
Physician Lead ImproveCareNow, Seattle Children's Hospital
Professor of Pediatrics, Division of Gastroenterology, Department of Pediatrics, University of Washington
Integrative Analysis of Microbiome and Other -Omics Data
Michael Wu, Ph.D.
Associate Member, Public Health Sciences Division, Fred Hutchinson Cancer Research Center
Affiliate Associate Professor, Department of Biostatistics, School of Public Health, University of Washington
Gene-level metagenomics systematically identifies culturable microbial isolates which are reproducibly associated with human disease
Samuel Minot, Ph.D.
Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center
Deciphering the human microbiota using chemistry
Emily Balskus, Ph.D.
Professor, Department of Chemistry and Chemical Biology, Harvard University; Member, Broad Institute of MIT and Harvard
Faculty Associate, Microbial Sciences Initiative, Member, MIT Center for Microbiome Informatics and Therapeutics
Metabolomics of the microbiome at data repository scale
Pieter C. Dorrestein, Ph.D.
Professor, Skaggs School of Pharmacy and Pharmaceutical Sciences, Departments of Pharmacology and Pediatrics
Director, Collaborative Mass Spectrometry Innovation Center
Co-Director, Institute for Metabolomics Medicine, University of California San Diego
Developmental Programming of the Gut Microbiome
Julia Yue Cui, Ph.D.
Sheldon D. Murphy Endowed Chair in Toxicology and Environmental Health and Assistant Professor, Department of Environmental and Occupational Health Sciences, University of Washington